Engineered Exosomes Deliver Gene-Silencing Drugs to Brain and Kidney Cells
Engineered exosomes represent a paradigm shift in gene therapy delivery, successfully bypassing the “liver sink” to target brain and kidney cells. This breakthrough expands the total addressable market for genetic ... Read More